Reprogramming allows us to turn any cell of the body into a stem cell. Since its discovery in 2006 the technique has become widely used in labs around the world. But the process is inefficient and many questions remain about how reprogramming works. PhD student James O'Malley is studying some of these challenging issues. Here he talks about his latest findings, which were published in the journal Nature on 2 June 2013.
In questo periodo, diverse dichiarazioni hanno suggerito che le cellule staminali possano già essere impiegate oggi nel trattamento di persone affette da neuropatologie. Ma cosa si sa veramente di queste terapie e come interpretare queste dichiarazioni?
There have been several claims that stem cells can already be used in patients affected by neurological disorders. What do we really know about these therapies and how should these claims be viewed?
Translating laboratory research into cell therapies raises many complex questions and challenges for both science and society. Social scientist Emma King spent four years following a regenerative medicine research project to examine how clinical translation might work in practice. Here, she reflects on what she learnt and what it might mean for the development of future therapies.
Pre-clinical research has generated some very promising findings using adult stem cells for the treatment of diabetic wounds. The research carried out by scientists at NUI Galway, is published in this month’s Diabetes the official journal of the American Diabetes Association.
 |  |
© Copyright 2008-2013 EuroStemCell i poszczególni autorzy
